Biotech Startups

Inaedis develops RTAD (Room Temperature Ambient Drying), a biopharmaceutical formulation platform that enables alternative drug delivery routes for monoclonal antibodies and biologics, including subcutaneous, inhaled, and intranasal administration. The platform reduces manufacturing risk and cost for pharmaceutical companies while improving patient access through room-temperature stability and simplified administration.

2 investors

InCurA develops medical devices focused on bleeding control and hemostatic solutions for surgical, dental, and emergency applications, with manufacturing and distribution across the MENA region and GCC countries. The company uses machine learning-optimized R&D to identify medical needs and commercialize biomedical innovations in markets with access gaps.

2 investors

Incyte is a biopharmaceutical company that develops and commercializes medicines for oncology, hematology, dermatology, and other therapeutic areas. The company focuses on bringing treatments to patients across multiple disease categories.

2 investors

Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech. The company focuses on drug candidates targeting ovarian and pancreatic cancer.

2 investors

Indomo Tx develops drug delivery technology focused on dermatology and consumer health, aiming to improve patient outcomes by helping individuals manage their own health. It is backed by a team with expertise in drug delivery, dermatology, and clinical and pharmaceutical fields.

2 investors

Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.

2 investors

Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins. The technology, developed at Johns Hopkins University's Laboratory of Precision Immunology, is used for immunology and diagnostics research.

2 investors

InflaRx is a biopharmaceutical company developing therapeutics that target the complement system to treat inflammatory diseases.

2 investors

Info Edge is a platform that invests in and operates early-stage internet ventures across multiple sectors including food delivery, insurance comparison, printing, SaaS, agriculture, healthcare, logistics, and edtech. The company provides financial and strategic support to portfolio companies to create and scale online businesses.

2 investors

Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.

2 investors

ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company leverages its management team's extensive experience in drug development and commercialization across all stages.

2 investors

Neonatal care technology developer for preterm and full-term infants.

2 investors

InnAVasc develops a vascular access graft for hemodialysis, featuring self-sealing pods and puncture-resistant backplates that guide dialysis needle placement to reduce needle-injury and bleeding complications. The product targets patients requiring hemodialysis access.

2 investors

Innocent Meat develops an automated cultured meat production system that enables conventional meat processors to manufacture lab-grown minced meat in-house using AI-controlled bioreactors, with integrated supply chain support for biological ingredients. The plug-and-play solution requires minimal space and specialized knowledge, targeting existing meat factories seeking to reduce animal agriculture reliance.

2 investors

Innomost develops biobased raw materials from birch bark for use in cosmetics, packaging, coatings, adhesives, and industrial applications, replacing fossil-based alternatives. The company transforms forest industry byproducts into high-value ingredients for manufacturers seeking circular, renewable material solutions.

2 investors

Innoup Farma is a pharmaceutical company developing oral immunotherapies and novel drug formulations, including mRNA-based vaccines and treatments for allergies, cancer, and rare diseases. The company is based in Spain and works on translating innovative biotech solutions into clinical applications.

2 investors

Innovation Works is a Pittsburgh-based startup investor whose portfolio page presents companies across software, robotics, healthcare, and hardware in Southwestern Pennsylvania. The page profiles portfolio companies rather than a single product.

2 investors

Inscopix develops advanced microscopy and neural circuit analysis technologies to understand brain function and disease mechanisms for neuroscience research. The company works with academic institutions, biopharmaceutical companies, and government agencies to translate research into therapies for neurological and psychiatric disorders including depression, Parkinson's, Alzheimer's, and PTSD.

2 investors

InSpek develops integrated photonic sensing technologies for chemical detection applications, translating chip-scale spectroscopic techniques from research into commercial deployment.

2 investors

Instapath operates an automated digital pathology lab, providing automated tissue imaging and processing for the medical diagnostics field. The company builds medical devices for pathology workflows.

2 investors

Intact Therapeutics is developing an advanced materials platform that uses smart gels to deliver and absorb drugs locally within the digestive tract. The company aims to improve treatment for a range of gastrointestinal disorders.

2 investors

Integrated Biosciences is a biotech company developing treatments and interventions for aging-related diseases using a combination of medicinal chemistry, biochemistry, aging biology, and artificial intelligence.

2 investors

IntegriChain provides a data platform that helps biopharmaceutical companies optimize net revenue performance and ensure patient access to therapies. The company serves established and emerging biopharma manufacturers by managing pricing, rebates, claims, and patient data across their commercial operations.

2 investors

Intellicyt (now part of Sartorius) develops the iQue high-throughput screening (HTS) flow cytometry platform, which combines sampling hardware and analysis software to generate multiplexed cell phenotype and function data from 96- or 384-well plates. It serves life science researchers working in areas such as antibody discovery, T-cell engineering, and immuno-oncology.

2 investors